This page shows the publications co-authored by Robert Langer and Elazer Edelman.
Quantification of insulin release from implantable polymer-based delivery systems and augmentation of therapeutic effect with simultaneous release of somatostatin. J Pharm Sci. 1996 Dec; 85(12):1271-5.
A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Biomaterials. 2016 07; 93:71-82.
Optimization of release from magnetically controlled polymeric drug release devices. Biomaterials. 1993 Jul; 14(8):621-6.
Mechanical deformation of polymer matrix controlled release devices modulates drug release. J Biomed Mater Res. 1992 Dec; 26(12):1619-31.
Controlled release and magnetically modulated systems for macromolecular drugs. Ann N Y Acad Sci. 1985; 446:1-13.
Modulated release from polymeric drug delivery systems using oscillating magnetic fields: in vitro and in vivo characteristics. Trans Am Soc Artif Intern Organs. 1984; 30:445-9.
Characterization of glucose-mediated insulin release from implantable polymers. J Pharm Sci. 1996 Dec; 85(12):1341-5.
Controlled and modulated release of basic fibroblast growth factor. Biomaterials. 1991 Sep; 12(7):619-26.
Transdermal delivery of heparin by skin electroporation. Biotechnology (N Y). 1995 Nov; 13(11):1205-9.
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature. 1992 Sep 03; 359(6390):67-70.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.